Capstone Investment Advisors’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41M | Sell |
16,162
-20,452
| -56% | -$1.79M | ﹤0.01% | 344 |
|
|
2025
Q1 | $2.5M | Sell |
36,614
-17,648
| -33% | -$1.21M | 0.01% | 255 |
|
|
2024
Q4 | $4.22M | Sell |
54,262
-8,740
| -14% | -$680K | 0.01% | 193 |
|
|
2024
Q3 | $4.22M | Buy |
63,002
+32,294
| +105% | +$2.16M | 0.01% | 134 |
|
|
2024
Q2 | $3.48M | Buy |
30,708
+26,476
| +626% | +$3M | 0.01% | 161 |
|
|
2024
Q1 | $587K | Buy |
4,232
+1,178
| +39% | +$163K | ﹤0.01% | 772 |
|
|
2023
Q4 | $379K | Sell |
3,054
-5,035
| -62% | -$625K | ﹤0.01% | 614 |
|
|
2023
Q3 | $755K | Buy |
+8,089
| New | +$755K | ﹤0.01% | 453 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 893 |
|
|
2023
Q1 | – | Sell |
-5,494
| Closed | -$622K | – | 658 |
|
|
2022
Q4 | $622K | Sell |
5,494
-16,869
| -75% | -$1.91M | ﹤0.01% | 437 |
|
|
2022
Q3 | $1.8M | Buy |
22,363
+16,095
| +257% | +$1.3M | 0.01% | 367 |
|
|
2022
Q2 | $467K | Buy |
+6,268
| New | +$467K | ﹤0.01% | 535 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 1009 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 874 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 964 |
|
|
2021
Q2 | – | Sell |
-10,248
| Closed | -$921K | – | 769 |
|
|
2021
Q1 | $921K | Sell |
10,248
-10,720
| -51% | -$963K | ﹤0.01% | 265 |
|
|
2020
Q4 | $1.94M | Buy |
+20,968
| New | +$1.94M | 0.01% | 176 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 420 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 387 |
|